GL1X · GenesisL1 explorer

Ligand · N15

N15 · 2-{4-[3-(1H-benzimidazol-2-yl)-1H-indazol-6-yl]-1H-pyrazol-1-yl}-N-(3-methylbutyl)acetamide

N15, 2-{4-[3-(1H-benzimidazol-2-yl)-1H-indazol-6-yl]-1H-pyrazol-1-yl}-N-(3-methylbutyl)acetamide (C24 H25 N7 O, 427.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues…

Component
N15
Formula
C24 H25 N7 O
Class
ligand
Structures
2
PDB entries
1

Binding sites

N15 in 2 structures; the first of them:

  • 3W2C · Structure of Aurora kinase A complexed to benzoimidazole-indazole inhibitor XV · N15 A401 · binds ARG137, LEU139, PHE144, VAL147, ALA160, LYS162, GLU181, VAL182 and 13 more
  • 3W2C · Structure of aurora kinase a complexed to benzoimidazole-indazole inhibitor xv · N15 A401 · binds ARG137, LEU139, PHE144, VAL147, ALA160, LYS162, GLU181, VAL182 and 13 more

Residues it binds most

LEU 8, ALA 8, VAL 8, GLU 8, ARG 8, ASP 8, GLN 8, GLY 8, LYS 8, PHE 8 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.